|
ZBTB11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.22030000000184E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.216400E-04 |
| Normal-vs-Stage2 |
7.89680000000681E-05 |
| Normal-vs-Stage3 |
1.634989999999E-05 |
| Normal-vs-Stage4 |
1.995650E-04 |
| Stage1-vs-Stage2 |
1.097010E-01 |
| Stage1-vs-Stage3 |
9.754400E-02 |
| Stage1-vs-Stage4 |
2.668600E-01 |
| Stage2-vs-Stage3 |
7.072800E-01 |
| Stage2-vs-Stage4 |
6.621200E-01 |
| Stage3-vs-Stage4 |
8.943000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.35519999999867E-05 |
| Normal-vs-AfricanAmerican |
1.358820E-01 |
| Normal-vs-Asian |
4.603700E-03 |
| Caucasian-vs-AfricanAmerican |
2.564600E-01 |
| Caucasian-vs-Asian |
7.340600E-01 |
| AfricanAmerican-vs-Asian |
4.472800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05219999999118E-05 |
| Normal-vs-Female |
1.597030E-04 |
| Male-vs-Female |
4.685200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.818200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.01339999994499E-06 |
| Normal-vs-Age(61-80Yrs) |
5.75520000000163E-05 |
| Normal-vs-Age(81-100Yrs) |
2.984400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.812160E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.478400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.821600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.736600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.763600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.764000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.659000E-01 |
| Classical-VS-Follicular |
4.610400E-04 |
| Classical-VS-Other |
5.245400E-01 |
| Classical-VS-Normal |
3.018800E-03 |
| Tall-VS-Follicular |
2.747600E-01 |
| Tall-VS-Other |
9.462400E-01 |
| Tall-VS-Normal |
2.101900E-03 |
| Follicular-VS-Other |
5.952600E-01 |
| Follicular-VS-Normal |
3.6881999998517E-07 |
| Other-VS-Normal |
6.274000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.1794000000529E-06 |
| Normal-vs-N1 |
1.643080E-03 |
| N0-vs-N1 |
4.530400E-01 |
|
|
